Stephanie Lovell - Jun 14, 2022 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Stock symbol
CYCN
Transactions as of
Jun 14, 2022
Transactions value $
$0
Form type
4
Date filed
6/16/2022, 08:56 PM
Previous filing
Jun 6, 2022
Next filing
Nov 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Stock Option (Right to Buy) Award $0 +20K $0.00 20K Jun 14, 2022 Common Stock 20K $0.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.